Shareholdings
| Concept |
As at 2022-02-28 |
2021-03-01 to 2022-02-28 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues |
15
xbrli:pure
|
— |
| Carrying amount |
993,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
1
xbrli:pure
|
| Total acquisition cost for increased shares | — |
200,000,000
JPY
|
| Reason for increase in number of shares | — |
医薬品開発における関係強化のための取得。
|
| Number of issues whose number of shares decreased | — |
1
xbrli:pure
|
| Total sale amount for decreased shares | — |
1,000,000
JPY
|
| Shares other than those not listed | ||
| Number of issues |
73
xbrli:pure
|
— |
| Carrying amount |
44,465,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
4
xbrli:pure
|
| Total acquisition cost for increased shares | — |
14,000,000
JPY
|
| Reason for increase in number of shares | — |
取引先持株会を通じた取得。
|
| Number of issues whose number of shares decreased | — |
1
xbrli:pure
|
| Total sale amount for decreased shares | — |
928,000,000
JPY
|